IP Library Granted Patent US 8,888,838
Granted Patent B2
US 8,888,838 · App. 13/167,547 · Granted Nov 18, 2014

Endoprosthesis containing multi-phase ferrous steel

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,888,838
App. No.
13/167,547
Granted
Nov 18, 2014
Kind
B2
Abstract

An endoprosthesis fabricated from multi-phase ferrous steel. Endoprostheses can include a variety of devices such as staples, orthodontic wires, heart valves, filter devices, and stents, many of which devices are diametrically expandable devices. Multi-phase ferrous steels include dual phase steels and transformation induced plasticity steels (TRIP steels).

Claims (32)

1. A medical device comprising a multiphase stainless steel alloy, wherein the stainless steel alloy comprises iron, chromium, nickel, tungsten, molybdenum, nitrogen, carbon, silicon, and manganese, wherein the multiphase stainless steel alloy has a volume fraction of ferrite comprising 11% or less, and wherein the device comprises an endoprosthesis.

2. The medical device of claim 1 , wherein the stainless steel alloy comprises 16.0-18.0 wt % chromium.

3. The medical device of claim 1 , wherein the stainless steel alloy comprises 6.0-8.0 wt % nickel.

4. The medical device of claim 1 , wherein the stainless steel alloy comprises 0.8-1.2 wt % tungsten.

5. The medical device of claim 1 , wherein the stainless steel alloy comprises 0.6-0.9 wt % molybdenum.

6. The medical device of claim 1 , wherein the stainless steel alloy comprises 0.2-0.3 wt % nitrogen.

7. The medical device of claim 1 , wherein the stainless steel alloy comprises at most 2.0 wt % manganese.

8. The medical device of claim 1 , wherein the stainless steel alloy comprises at most 0.75 wt % silicon.

9. The medical device of claim 1 , wherein the stainless steel alloy comprises at most 0.03 wt % carbon.

10. The medical device of claim 1 , wherein the stainless steel alloy further comprises phosphorus.

11. The medical device of claim 10 , wherein the stainless steel alloy further comprises at most 0.03 wt % phosphorus.

12. The medical device of claim 1 , wherein the stainless steel alloy further comprises sulfur.

13. The medical device of claim 12 , wherein the stainless steel alloy further comprises at most 0.02 wt % sulfur.

14. The medical device of claim 1 , wherein the stainless steel alloy consists of iron, 16.0-18.0 wt % chromium, 6.0-8.0 wt % nickel, 0.8-1.2 wt % tungsten, 0.6-0.9 wt % molybdenum, 0.2-0.3 wt % nitrogen, at most 2.0 wt % manganese, at most 0.75 wt % silicon, at most 0.03 wt % carbon, at most 0.03 wt % phosphorus, and at most 0.02 wt % sulfur.

15. The medical device of claim 1 , wherein the medical device is MRI-compatible.

16. The medical device of claim 1 , wherein the stainless steel alloy has a volume fraction of ferrite of about 5% or less.

17. The medical device of claim 1 , wherein the stainless steel alloy is annealed, having a strength greater than an annealed 316L stainless steel, lower work hardening than an annealed L605, and elongation between 50-100%.

18. The medical device of claim 1 , wherein the stainless steel alloy is non-magnetic.

19. The medical device of claim 1 , wherein the pitting resistance number of the stainless steel alloy is higher than that of 316L stainless steel.

20. The medical device of claim 19 , wherein the pitting resistance number of the stainless steel alloy is about 25.

21. The medical device of claim 1 , wherein the stainless steel alloy has an elastic recoil less than that of L605.

22. The medical device of claim 1 , wherein the corrosion resistance of the stainless steel alloy is equivalent to that of 316L stainless steel.

23. The medical device of claim 1 , wherein the endoprosthesis comprises a balloon expandable stent.

24. The medical device of claim 23 , further comprising a balloon catheter coupled to the balloon expandable stent.

25. The medical device of claim 24 , wherein the balloon expandable stent is mounted on the balloon catheter.

26. The medical device of claim 24 , wherein the balloon expandable stent is crimped onto the balloon catheter.

27. The medical device of claim 24 , wherein the balloon catheter is positioned along a longitudinal axis of the balloon expandable stent.

28. The medical device of claim 23 , wherein at least a portion of the balloon expandable stent is covered with a polymeric material.

29. The medical device of claim 28 , wherein the polymeric material comprises a fluoropolymer.

30. The medical device of claim 28 , wherein the polymeric material comprises a copolymer of tetrafluoroethylene and a polyalkylvinylether.

31. The medical device of claim 28 , wherein the polymeric material comprises a bioactive substance.

32. The medical device of claim 23 , wherein at least a portion of the balloon expandable stent is coated with a bioactive substance.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2012
From: GORE ENTERPRISE HOLDINGS, INC.
To: W. L. GORE & ASSOCIATES, INC.
Reel/Frame 027906/0508 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2011
From: BLANZY, JEFFREY S.
To: GORE ENTERPRISE HOLDINGS, INC.
Reel/Frame 026645/0646 →